En
Fr
(
Fr
)
Contact Us
Home
About Us
Our Company
Our strategy
Meet the Management Team
Our Board Members
Plasma Resources
Product pipeline
R&D Pipeline
PBI-4050
Alström Syndrome
Idiopathic Pulmonary Fibrosis
PBI-4547
Selective GPR84 Antagonist
Selective OXER1 Antagonist
Plasminogen Deficiency
Scientific Posters
Investors & Media
Investor Resources
Press releases
Financial Reports
Webcasts
Stock information
SEC Filings
Corporate governance
Investor Briefcase
Frequently asked questions
Careers
Career Opportunities
Resume submission
Subscribe
Investor Resources
Investor Resources
Latest Content
Press Releases
Press Releases
Press Releases 2020
Press Releases 2019
Press Releases 2018
Scientific Posters
Scientific Posters
PBI-4050
PBI-4547
GPR40 & GPR84
Financial Reports
Financial Reports
Financial Reports 2020
Financial Reports 2019
Financial Reports 2018
Corporate Documents
Corporate Documents
Corporate Governance Documentation
Videos & Webcasts
Videos & Webcasts
Our Technology
Alstrom Syndrome
Idiopathic Pulmonary Fibrosis (IPF)
Plasminogen Deficiency (PLGD)
Webcasts
×
Home
»
Financial Reports 2019
»
Quarterly Report 2019 Q1
×
Share this Presentation
Facebook
Twitter
Email
LinkedIn
Quarterly Report 2019 Q1
May 14, 2019
Share this Flipbook
Facebook
Twitter
Email
LinkedIn
Previous Flipbook
Quarterly Report 2019 Q2
No More Flipbooks
Most Recent Flipbooks
‹
›
Annual Report 2019
Read PDF
Quarterly Report Q3 2019
Read PDF
Quarterly Report 2019 Q2
Read PDF
Return to Home
×
Streams
Latest Content
Press Releases
Press Releases 2020
Press Releases 2019
Press Releases 2018
Scientific Posters
PBI-4050
PBI-4547
GPR40 & GPR84
Financial Reports
Financial Reports 2020
Financial Reports 2019
Financial Reports 2018
Corporate Documents
Corporate Governance Documentation
Videos & Webcasts
Our Technology
Alstrom Syndrome
Idiopathic Pulmonary Fibrosis (IPF)
Plasminogen Deficiency (PLGD)
Webcasts
Share this Hub
Facebook
Twitter
Email
LinkedIn
×
